【辉瑞意外终止血友病协议 Sangamo(SGMO.US)股价盘后一度暴跌超69%】在美国医药巨头辉瑞(PFE.US)意外终止其开发治疗A型血友病的新型基因疗法的相关合作之后,Sangamo Therapeutics(SGMO.US)股价在美股市场的盘后交易中一度暴跌超69%,截至发稿跌超58%。

金融界
31 Dec 2024
在美国医药巨头辉瑞(PFE.US)意外终止其开发治疗A型血友病的新型基因疗法的相关合作之后,Sangamo Therapeutics(SGMO.US)股价在美股市场的盘后交易中一度暴跌超69%,截至发稿跌超58%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10